医学
内科学
胃肠病学
C反应蛋白
溃疡性结肠炎
前瞻性队列研究
回顾性队列研究
队列
外科
疾病
炎症
作者
Pauline Rivière,Anne Le Chevillier,Anne Rullier,Marion Marty,Erwin Schurr,Bruno Lapuyade,Bertrand Célérier,Benjamı́n Fernández,Talat Bessissow,Xavier Tréton,Mathieu Uzzan,Florian Poullenot,Arthur Berger,Frank Zerbib,David Laharie
标识
DOI:10.1016/j.dld.2023.05.004
摘要
Increased C-reactive protein (CRP) is used to diagnose and predict response to treatment in acute severe ulcerative colitis (UC).To investigate the connection between CRP elevation and deep ulcers in UC.Patients with active UC were enrolled in a multicenter prospective cohort and a retrospective cohort of consecutive patients undergoing colectomy from 2012 to 2019.Forty-one (9 (22%) with deep ulcers) patients were included in the prospective cohort: 4/5 (80%) patients with CRP > 100 mg/L, 2/10 (20%) patients with CRP between 30 and 100 mg/L and 3/26 (12%) patients with CRP < 30 mg/L had deep ulcers (p = 0.006). In the retrospective cohort [46 patients (31 (67%) with deep ulcers)], 14/14 (100%) patients with CRP > 100 mg/L, 11/17 (65%) patients with CRP between 30 and 100 mg/l and 6/15 (40%) patients with CRP < 30 mg/L had deep ulcers (p = 0.001). Positive predictive value of CRP > 100 mg/l for presence of deep ulcers was 80% and 100% in both cohorts, respectively.CRP elevation is a robust surrogate marker for presence of deep ulcers in UC. Elevated CRP or presence of deep ulcers could influence the choice of medical therapy in acute severe UC.
科研通智能强力驱动
Strongly Powered by AbleSci AI